Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Tracking the impact of government response to COVID-19 epidemic: Evidence from India

View ORCID ProfileKaibalyapati Mishra
doi: https://doi.org/10.1101/2023.11.27.23299097
Kaibalyapati Mishra
1CESP, ISEC, Bangalore, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kaibalyapati Mishra
  • For correspondence: kpmishra1998{at}gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

This paper tries to quantify the impact of government policy intervention on the death due to COVID-19 in India at national, regional and sub-national levels. The data used for this study are collected from the Oxford COVID-19 Government Response Tracker (OxCGRT), a longitudinal database of daily government response from Jan 28th, 2020, when the first COVID case was diagnosed in India till December 31st, 2022. Here, stringency measures, which gauge the severity of interventions such as lock-downs and travel restrictions, indicative of government control; and containment measures, representing a spectrum of actions aimed at preventing or limiting virus transmission and the overall government support, providing a holistic assessment of the government’s efforts in mitigating the virus’s spread. Using the Panel Corrected Standard Error (PCSE) method, this paper finds out that the stringency and overall government support interventions by the government have been successful in reducing the death counts by 25% and 23% respectively however the containment intervention alone has failed to reduce the death at all levels. Exploring regional variations, event study plots reveal nuanced temporal dynamics. The daily and 24-day lagged dependent variables, representing overall government response and stringency measures, reveal a consistent impact post-intervention at the all-India level. Both current and lagged variables show a reduction in COVID-19 deaths, with a more pronounced effect emerging after a four-day lag. Event-study plots with a 24-day lagged dependent variable confirm the anticipated negative impact of overall government response on deaths. However, the pattern diverges for stringency and overall government interventions compared to daily death counts.

JEL Classifications I18, I38, C23, C54

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study uses data openly available at OXCGRT database hosted by Oxford University.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced are available online at OXCGRT Database

https://www.bsg.ox.ac.uk/research/covid-19-government-response-tracker

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 29, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Tracking the impact of government response to COVID-19 epidemic: Evidence from India
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Tracking the impact of government response to COVID-19 epidemic: Evidence from India
Kaibalyapati Mishra
medRxiv 2023.11.27.23299097; doi: https://doi.org/10.1101/2023.11.27.23299097
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Tracking the impact of government response to COVID-19 epidemic: Evidence from India
Kaibalyapati Mishra
medRxiv 2023.11.27.23299097; doi: https://doi.org/10.1101/2023.11.27.23299097

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Economics
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)